Biogen reported $1.74B in Cash and Equivalent for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Acadia Pharmaceuticals ACAD:US $ 304.49M 21.54M
Acorda Therapeutics ACOR:US $ 116.77M 45.4M
Alexion Pharmaceuticals ALXN:US $ 3429.6M 465.1M
ALKERMES ALKS:US $ 258.34M 53.31M
Amgen AMGN:US $ 6112M 154M
Bayer BAYN:GR € 5550M 1359M
Biogen BIIB:US $ 1742M 524.5M
Biomarin Pharmaceutical BMRN:US $ 641.53M 25.78M
Bluebird Bio BLUE:US $ 439.71M 122.01M
Bristol Myers Squibb BMY:US $ 11024M 42M
Eli Lilly And LLY:US $ 3002.4M 654.7M
Esperion Therapeutics ESPR:US $ 217.94M 87.02M
Gilead Sciences GILD:US $ 7361M 3296M
Gw Pharmaceuticals GWPH:US $ 458.1M 28.65M
Intercept Pharmaceuticals ICPT:US $ 145.62M 52.67M
Intra Cellular Therapies ITCI:US $ 129.98M 69.93M
Marinus Pharmaceuticals MRNS:US $ 123.47M 15.04M
Moderna Inc MRNA:US 5.44B 2.82B
Neurocrine Biosciences NBIX:US $ 352.6M 165.5M
Novartis NOVN:VX SF 3801M 5857M
Ptc Therapeutics PTCT:US $ 177.35M 30.72M
Puma Biotechnology PBYI:US $ 95.65M 10.36M
Regeneron Pharmaceuticals REGN:US $ 1437.9M 755.8M
Sangamo Biosciences SGMO:US $ 122.98M 8.35M
Sarepta Therapeutics SRPT:US $ 1481.84M 20.81M
Seattle Genetics SGEN:US $ 413.43M 39.72M
Teva Pharmaceutical TEVA:IT 2.44B 693M
Ultragenyx Pharmaceutical RARE:US $ 383.79M 329.73M
United Therapeutics UTHR:US $ 832.3M 93.6M
Vertex Pharmaceuticals VRTX:US $ 6707.99M 403.66M
YTE INCY:US $ 1962.39M 449.38M